Quantification of human intravenous immunoglobulin from plasma and in process samples by affinity chromatography
M Mozgovicz, N Lingg, ITL Bresolin… - Preparative …, 2024 - Taylor & Francis
Advances in affinity chromatography now make it possible to analyze immunoglobulin G
from plasma and its fractions with a simple chromatographic method. Ligands derived from …
from plasma and its fractions with a simple chromatographic method. Ligands derived from …
Two Patients with Therapy-Resistant Pemphigus Vulgaris and Severe Underlying Disease Showing Good Response to a New IVIg Preparation
K Hogrefe, JK Winkler, AH Enk - Dermatology and Therapy, 2025 - Springer
Pemphigus vulgaris is a severe and often therapy-resistant bullous autoimmune disease.
Standard therapy with steroids often administered together with another …
Standard therapy with steroids often administered together with another …
Successful Treatment of Severe Pemphigus Vulgaris with Reduced Side Effects Using a Novel IVIg Preparation
N Wiedenmayer, AS Vollmer, JK Winkler… - Dermatology and …, 2024 - Springer
Pemphigus vulgaris (PV) is a rare autoimmune bullous dermatosis (AIBD) characterized by
painful blistering of the skin and mucosa caused by autoantibodies that lead to loss of …
painful blistering of the skin and mucosa caused by autoantibodies that lead to loss of …
Case report: A novel high‐dose intravenous immunoglobulin preparation for the treatment of severe pemphigus vulgaris failing standard therapy
N Wiedenmayer, K Hogrefe… - The Journal of …, 2024 - Wiley Online Library
Pemphigus vulgaris (PV) is a severe autoimmune bullous dermatosis that is characterized
by autoantibodies against epidermal adhesion proteins causing painful mucosal and skin …
by autoantibodies against epidermal adhesion proteins causing painful mucosal and skin …
Treatment of a Complex Case of Scleromyxedema Using a Novel Intravenous Immunoglobulin Preparation
AS Vollmer, N Wiedenmayer, JK Winkler… - Case Reports in …, 2024 - karger.com
Introduction: We provide a case report on a patient with scleromyxedema treated with high-
dose intravenous immunoglobulins (IVIgs) who reported less fatigue and fewer headaches …
dose intravenous immunoglobulins (IVIgs) who reported less fatigue and fewer headaches …